Latest Regulation News

Heavy Minerals Limited is on track to release its Port Gregory Garnet Project Pre-Feasibility Study in Q3 2025, while advancing promising industrial minerals testing and preparing its mining lease application.

Epsilon Healthcare has emerged from voluntary administration with a stronger balance sheet, securing refinancing and preparing to launch its new pharmacy platform. Operational stability and strategic initiatives signal a turning point for the healthcare group.

BPH Energy’s June quarter update highlights ongoing legal proceedings over the PEP-11 permit, promising progress in AI-driven brain monitoring technology, and strategic moves toward hydrogen production facilities, supported by a robust cash reserve.

NuEnergy Gas Limited has completed drilling two wells at its Tanjung Enim PSC in Indonesia, advancing its early gas sales initiative targeting 1 million cubic feet per day. The company is finalizing a major gas sales agreement pending government approval.

Platformo Ltd’s Biztrak business reported a robust 41% revenue increase in the June 2025 quarter, driven by software enhancements and training tied to Malaysia’s evolving e-invoicing regulations. The company also tightened cost controls, reducing net cash outflow while preparing for upcoming compliance deadlines.

UNITH Ltd reported a record quarterly cash receipt of $1.6 million in Q4 FY25, driven by strategic partnerships and platform innovations. The company is poised for growth with a new website launch and expanded European presence.

Torque Metals has initiated diamond drilling at its Paris Gold Project to extend promising high-grade gold mineralisation, leveraging government co-funding and advanced geophysical targeting.

OD6 Metals has reported strong high-grade copper results from its maiden drilling at Gulf Creek, NSW, alongside progress in rare earth metallurgical testing and closure of a regulatory investigation.

Imricor Medical Systems reported significant regulatory and commercial progress in Q2 CY25, including CE mark approvals and expanded clinical trials, while maintaining a strong cash position.

Sprintex has landed a landmark three-year private-label supply agreement worth A$9.3 million with Guangdong Baode Technology, marking its entry into China’s vast aquaculture market.

BlinkLab is advancing its FDA 510(k) clinical trials for autism and ADHD diagnostics, completing its U.S. autism pilot phase and expanding European ADHD recruitment. A recent $7.66 million capital raise supports these efforts as the company targets regulatory approvals in 2026.

Singular Health has landed a pivotal $2 million US pilot contract with Provider Network Solutions and completed an $8 million capital raise, advancing its medical imaging platform’s regulatory and product development milestones.